NM_004995.4:c.1292G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_004995.4(MMP14):​c.1292G>A​(p.Arg431His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000554 in 1,614,050 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00078 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 5 hom. )

Consequence

MMP14
NM_004995.4 missense

Scores

1
9
8

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 2.46

Publications

11 publications found
Variant links:
Genes affected
MMP14 (HGNC:7160): (matrix metallopeptidase 14) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily; each member of this subfamily contains a potential transmembrane domain suggesting that these proteins are expressed at the cell surface rather than secreted. This protein activates MMP2 protein, and this activity may be involved in tumor invasion. [provided by RefSeq, Jul 2008]
MMP14 Gene-Disease associations (from GenCC):
  • Winchester syndrome
    Inheritance: AR, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • multicentric osteolysis-nodulosis-arthropathy spectrum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0105009675).
BP6
Variant 14-22844771-G-A is Benign according to our data. Variant chr14-22844771-G-A is described in ClinVar as Benign. ClinVar VariationId is 717373.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000775 (118/152212) while in subpopulation EAS AF = 0.0201 (104/5184). AF 95% confidence interval is 0.0169. There are 1 homozygotes in GnomAd4. There are 64 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMP14NM_004995.4 linkc.1292G>A p.Arg431His missense_variant Exon 8 of 10 ENST00000311852.11 NP_004986.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMP14ENST00000311852.11 linkc.1292G>A p.Arg431His missense_variant Exon 8 of 10 1 NM_004995.4 ENSP00000308208.6

Frequencies

GnomAD3 genomes
AF:
0.000776
AC:
118
AN:
152094
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0200
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00182
AC:
458
AN:
251424
AF XY:
0.00160
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0223
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000531
AC:
776
AN:
1461838
Hom.:
5
Cov.:
32
AF XY:
0.000545
AC XY:
396
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.0141
AC:
560
AN:
39700
South Asian (SAS)
AF:
0.00116
AC:
100
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53382
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000513
AC:
57
AN:
1111998
Other (OTH)
AF:
0.000861
AC:
52
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
49
98
147
196
245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000775
AC:
118
AN:
152212
Hom.:
1
Cov.:
32
AF XY:
0.000860
AC XY:
64
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41516
American (AMR)
AF:
0.000131
AC:
2
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0201
AC:
104
AN:
5184
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68002
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000536
Hom.:
2
Bravo
AF:
0.00113
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00193
AC:
234
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

MMP14-related disorder Benign:1
Jun 13, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 12, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.13
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.18
T
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.86
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
2.5
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.24
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.022
D
Polyphen
1.0
D
Vest4
0.33
MVP
0.67
MPC
0.71
ClinPred
0.14
T
GERP RS
5.2
Varity_R
0.81
gMVP
0.53
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3751489; hg19: chr14-23313980; API